Jun
30
Tue
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104
Jun 30 @ 8:00 am – 9:00 am
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104

Presenter: Michaela Liedtke, MD, Assistant Professor of Medicine (Hematology)

Nov
8
Wed
Medicine Grand Rounds: Features and Outcomes of Methamphetamine Associated Pulmonary Arterial Hypertension @ LKSC, Berg Hall
Nov 8 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Features and Outcomes of Methamphetamine Associated Pulmonary Arterial Hypertension @ LKSC, Berg Hall | Palo Alto | California | United States

Presenters: Vinicio A. de Jesus Perez, MD and Roham Zamanian, MD
Perez: Assistant Professor of Medicine, Pulmonary and Critical Care
Zamanian: Associate Professor of Medicine, Pulmonary and Critical Care                                 Stanford University

Perez received his MD from the University of Puerto Rico Medical School and completed an internal medicine residency at Massachusetts General Hospital. He completed a fellowship in pulmonary and critical care medicine in Denver, followed by postdoctoral research training at Stanford University. He focused on researching genetic and molecular mechanisms of pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF) and has devoted his clinical practice to diagnosis and management of these conditions. He is presently assistant professor of medicine and staff physician of the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF.

As a medical professional belonging to a minority group, Dr. de Jesus Perez is involved in academic endeavors seeking to improve access of care for patients with disadvantageous ethnic backgrounds and promote diversity in medicine.

Zamanian specializes in the treatment of pulmonary hypertension, right heart failure, and pulmonary embolism. He has more than 13 years of sub-specialty experience in pulmonary vascular diseases. Dr. Zamanian is considered one of the leading national experts in clinical trials and drug development for pulmonary hypertension.

Feb
10
Sat
Stanford Interstitial Lung Disease Symposium: An Image-Centered Approach to Early Diagnosis and Treatment @ San Jose Marriott
Feb 10 all-day

Presented by the Division of Pulmonary and Critical Care and the Stanford University School of Medicine.

Please register early – space is limited!

This CME event led by the Stanford Division of Pulmonary and Critical Care seeks to fulfill the need of practicing pulmonologists, primary care physicians, advanced-practice providers, and allied health care practitioners in the academic and community settings to achieve an accurate diagnosis and implement a comprehensive treatment plan for patients with interstitial lung disease. A team of multidisciplinary experts will address common challenges in radiographic interpretation, diagnostic testing and classification, and disease management. The goal of the symposium is to improve the delivery of early appropriate, and comprehensive care to the patient with the interstitial lung disease.

 

TARGET AUDIENCE

This local and regional conference is designed to meet the educational needs of:

  • physicians
  • Nurses
  • Nurses practitioners
  • Health care professionals

LEARNING OBJECTIVES

At the conclusion of this activity, participants should be able to:

  • List critical findings in the history and physical exam specific to interstitial lung disease (ILD) patients
  • Describe serologic tests indicated for different populations of ILD patients with or without rheumatologic symptoms
  • Manage patients using diagnostic criteria outlined in the ATS ILD Guidelines
  • Use anti-fibrotic therapy for appropriate patients and develop comprehensive multidisciplinary management strategies
  • Utilize radiologic algorithms and classification criteria for fibrosing and nonfibrosing interstitial pneumonias
  • Determine the role of lung biopsy in the diagnosis of ILDs including patient selection, modality of biopsy, and risk/benefit analysis
  • Identify non-pharmacologic treatments to provide for ILD patients at their first clinic visit
  • Explain the criteria and timing for the referral of an ILD patient for a lung transplant evaluation
  • Describe the current status of stem cell research related to ILDs

COURSE DIRECTORS

Dr. Rishi Raj

Rishi Raj, MD

Course Director
Clinical Professor, Medicine – Pulmonary & Critical Care;
Director, Interstitial Lung Disease Program

Dr. Joshua Mooney

Joshua Mooney, MD, MS

Course Co-Director
Clinical Assistant Professor Medicine – Pulmonary & Critical Care Medicine;
Director, Stanford Pulmonary Fibrosis Foundation Care Center

Jul
25
Wed
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall
Jul 25 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Crystal Mackall, MD
Professor of Pediatric Hematology/Oncology and Medicine                                                          Stanford University

Crystal L Mackall MD is Endowed Professor of Pediatrics and Internal Medicine at Stanford University. She serves as Founding Director of the Stanford Center for Cancer Cell Therapy, Associate Director of Stanford Cancer Institute, Leader of the Cancer Immunology and Immunotherapy Program at Stanford and Director of the Parker Institute for Cancer Immunotherapy at Stanford. During her tenure as Head of the Immunology Section and Chief of the Pediatric Oncology Branch, NCI, she built an internationally recognized translational research program spanning basic studies of T cell homeostasis and tumor immunology, and clinical trials of immune based therapies for cancer. Her work is credited with identifying an essential role for the thymus in human T cell regeneration and discovering IL-7 as the master regulator of T cell homeostasis. She has led numerous cutting edge and first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines, and adoptive immunotherapy using NK cells and genetically modified T cells. Her group was among the first to demonstrate impressive activity of CD19-CAR in pediatric leukemia and recently demonstrated impressive activity of a second CAR targeting CD22.. Dr. Mackall’s clinical trials are notable for the incorporation of deep biologic endpoints that further our understanding of the basis for success and failure of the agent under study. She has published over 175 manuscripts and serves in numerous leadership positions, including Leader of the NCI Pediatric Cancer Immunotherapy Trials Network, co-Leader of the St. Baldrick’s-StandUp2Cancer Pediatric Dream Team. She is Board Certified in Pediatrics and Internal Medicine.
Dec
12
Wed
Medicine Grand Rounds: On Diagnosing Interstitial Lung Disease @ LKSC Berg Hall
Dec 12 @ 8:00 am – 9:00 am
Medicine Grand Rounds: On Diagnosing Interstitial Lung Disease @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Rishi Raj, MD

Clinical Professor of Pulmonary and Critical Care Medicine, Stanford University

Rishi Raj, MD, is an Clinical Professor of Medicine at Stanford University and directs the Interstitial Lung Disease program at Stanford. He specializes in the diagnosis and treatment of interstitial lung diseases and has practiced pulmonary and critical care medicine for more than 15 years. Raj’s primary clinical interest and primary focus of clinical research is interstitial lung diseases including idiopathic pulmonary fibrosis, other idiopathic interstitial lung diseases, drug induced interstitial lung diseases, interstitial lung disease associated with connective tissue diseases including scleroderma, rheumatoid arthritis, dermatomyositis etc., sarcoidosis, hypersensitivity pneumonitis and other miscellaneous interstitial lung diseases. Dr. Raj is the principal investigator and co-investigator on multiple clinical trials evaluating new therapies for treating idiopathic pulmonary fibrosis and pulmonary fibrosis/interstitial lung disease from other etiologies.

Jul
3
Wed
Medicine Grand Rounds: Idiopathic Pulmonary Fibrosis: A Disease in Search of a Cause @ LKSC Berg Hall
Jul 3 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Idiopathic Pulmonary Fibrosis: A Disease in Search of a Cause @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Tushar Desai, MD, MPH

Associate Professor of Pulmonary and Critical Care Medicine, Stanford University

Tushar Desai, MD, MPH, specializes in the treatment of general pulmonary and Interstitial Lung Diseases like Idiopathic Pulmonary Fibrosis (IPF). He has practiced pulmonary medicine since 2002. Desai has a special interest in understanding the development and progression of diseases like IPF, Chronic Obstructive Pulmonary Disease (COPD), and lung adenocarcinoma, as well as in understanding how native lung stem cells function to repair the lung gas exchange surface after injury.

Sep
16
Mon
12th Comprehensive Cancer Research Training Program (CCRTP) @ Bechtel Conference Center, Encina Hall
Sep 16 – Sep 17 all-day
12th Comprehensive Cancer Research Training Program (CCRTP) @ Bechtel Conference Center, Encina Hall

The Comprehensive Cancer Research Training Program is an annual two–day immersive course that invites graduate and postdoctoral students, residents, clinical fellows and research fellows to take part in a unique, comprehensive introduction to the vanguard of current cancer research.

This ambitious curriculum features daily plenary sessions on general topics followed by half-day sessions on two scientific themes, each featuring three to four presentations. Numerous nationally and internationally renowned Stanford faculty present didactic lectures and discussions on current topics of basic, translational and clinical cancer research.

REGISTER HERE.

Sep
24
Tue
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center
Sep 24 – Sep 26 all-day
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center

The Canary Center at Stanford, founded in 2009 as the first research center in the world, entirely dedicated to cancer early detection, The Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, and Cancer Research UK, the largest independent funder of cancer research globally have formed an international collaboration to accelerate research in the early detection of cancer.

The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.

The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:

  • A lack of cohorts of sufficient size and a shortage of clinical samples available for research
  • Development and deployment of new technologies
  • Lack of understanding of the biology of early cancer and technologies to detect its features

2019 conference topic list includes:

  • Integrative Early Detection through multiple technologies
  • Prognostic Early Detection
  • Signals from beyond the tumor
  • Integrative Susceptibility for Early Detection
  • Fostering a translational mentality in Early Detection Research

CLICK HERE TO REGISTER.

Oct
2
Wed
Medicine Grand Rounds: Blood, Breath, and Biomarkers: The Road to Precision Medicine in the ICU @ LKSC Berg Hall
Oct 2 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Blood, Breath, and Biomarkers: The Road to Precision Medicine in the ICU @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Angela Rogers, MD

Assistant Professor of Pulmonary and Critical Care Medicine, Stanford University

Angela Rogers, MD, is an expert in Pulmonary and Critical Care Medicine. She has practiced in these fields for 10 years. She has a special interest in ICU medicine, with a research focus on acute respiratory failure and ARDS. She researchers in blood biomarkers of these diseases, and is very active in teaching residents and fellows about critical care.

 

Jul
14
Wed
Medicine Grand Rounds: All hands on deck! Repair of acute lung injury @ Online only
Jul 14 @ 8:00 am – 9:00 am
Medicine Grand Rounds: All hands on deck! Repair of acute lung injury @ Online only | Palo Alto | California | United States

NOTE: This MGR is ONLINE-only.  

AGENDA

Feature Presentation:All hands on deck! Repair of acute lung injury

Presenter:

  • Tushar Desai, MD, Associate Professor of Medicine, Pulmonary and Critical Care, Stanford University

CME Accreditation:

To Claim CME Credit, Click here and enter the Activity ID: 37411

Disclosure Information found here.